Repligen's Leadership Team

Executive Management

Walter C. Herlihy, Ph.D.
President and Chief Executive Officer

William J. Kelly
Chief Financial Officer

James R. Rusche, Ph.D.
Senior Vice President, Research and Development

Howard Benjamin, Ph.D.
Vice President, Business Development

Stephen Tingley
Vice President, Bioprocessing Business Development

Laura L. Whitehouse
Vice President, Market Development

Daniel P. Witt, Ph.D.
Vice President, Operations

Board of Directors

Glenn L. Cooper, M.D.
Retired

Karen A. Dawes
President, Knowledgeable Decisions, LLC

Alfred L. Goldberg, Ph.D.
Professor of Cell Biology, Harvard Medical School

Earl Webb Henry, M.D.
Chief Medical Officer, inVentiv Clinical Solutions

Walter C. Herlihy, Ph.D.
President and Chief Executive Officer, Repligen Corporation

Alexander Rich, M.D.
Chairman, Board of Directors
Sedgwick Professor of Biophysics, Department of Biology, Massachusetts Institute of Technology

Thomas F. Ryan, Jr.
Retired/Private Investor